S&P 500: 666.06 -1.5% NASDAQ 100: 597.26 -1.7% Dow Jones: 467.48 -1.5%

Metlife Investment Management - Q4 2025 13F Filings

ME

Metlife Investment Management, LLC

CIK: 0001529735
Address: New Jersey Whippany One Metlife Way
$20.67 B
Portfolio Value
2808
Assets Held
Reporting Period: Q4 2025
Filing Status:
Active
Last Updated: 02/12/2026

Portfolio Summary (Q4 2025)

View Full Portfolio Analysis

Top Sells

Q4 2025
−$58.72 M
3. Rtx Corporation (Formerly Raytheon Tech)
−$55.57 M

Asset Allocation

Stocks/ETFs
-0.49%
$20.66 B 99.94%
Options
$0 0.00%
Debt
$0 0.00%
Other
-84.20%
$12.08 M 0.06%

Sector Allocation (Stocks)

Metlife Investment Management Q4 2025 Filing Summary

Metlife Investment Management, LLC filed its 13F report for Q4 2025 on February 12, 2026. The portfolio totaled 20.67 B reflecting a -0.80% change from the prior quarter, spanning 2,808 assets. The top 10 holdings comprised 30.5% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 55 new positions and 91 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Metlife Investment Management’s Q4 2025 Filing

Metlife Investment Management submitted their Form 13F-HR for the Q4 2025 period on 02/12/2026. This was the only submission for the quarter.

In the Q4 2025 filing, Metlife Investment Management reported a managed portfolio value of 20.67 B, consisting of 2,808 individual positions.

This page displays the raw filing documents. To see which stocks Metlife Investment Management bought or sold during Q4 2025, please visit Metlife Investment Management's Portfolio Analysis page.